Clinical trials
Observational Colorectal Neoplasms, Hereditary Nonpolyposis trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lei Li | 2 |
| M.D. Anderson Cancer Center | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Institut Claudius Regaud | 1 |
| London North West Healthcare NHS Trust | 1 |
| National Health Research Institutes, Taiwan | 1 |
| Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia | 1 |
| RWJ Barnabas Health at Jersey City Medical Center | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| Samsung Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 14 |
| Endometrial Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Adenomatous Polyposis Coli | 2 |
| Stomach Neoplasms | 2 |
| Colonic Neoplasms | 1 |
| Disease Susceptibility | 1 |
| Genetic Diseases, Inborn | 1 |
| Hamartoma Syndrome, Multiple | 1 |
| Hereditary Breast and Ovarian Cancer Syndrome | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.